Volume | 7,330 |
|
|||||
News | - | ||||||
Day High | 2.17 | Low High |
|||||
Day Low | 2.12 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.15 | 2.12 | 2.17 | 2.18 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
100 | 7,330 | $ 2.15 | $ 15,726 | - | 1.80 - 63.90 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
13:02:54 | 4 | $ 2.15 | USD |
MyMD Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.54M | 2.09M | - | 0 | -8.22M | -3.93 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
MyMD Pharmaceuticals News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.89 | 2.20 | 1.8648 | 2.04 | 33,846 | 0.28 | 14.81% |
1 Month | 2.20 | 2.445 | 1.80 | 1.99 | 129,397 | -0.03 | -1.36% |
3 Months | 2.87 | 3.50 | 1.80 | 2.52 | 268,233 | -0.70 | -24.39% |
6 Months | 7.86 | 10.665 | 1.80 | 5.81 | 775,290 | -5.69 | -72.39% |
1 Year | 49.20 | 63.90 | 1.80 | 14.88 | 762,244 | -47.03 | -95.59% |
3 Years | 139.50 | 298.50 | 1.80 | 51.21 | 416,659 | -137.33 | -98.44% |
5 Years | 162.90 | 298.50 | 1.80 | 57.12 | 423,405 | -160.73 | -98.67% |
MyMD Pharmaceuticals Description
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. |